Identifying in-market application of Pelargonium root extract EPs 7630 for the treatment of COVID-19: analysis of pharmacovigilance data

Introduction: Phytopharmaceutical products are successfully used for acute respiratory infections and may therefore be promising candidates for adjuvant symptomatic treatment of COVID-19. In vitro and clinical studies suggest that the proprietary Pelargonium sidoides DC. root extract EPs 7630 has an...

Full description

Bibliographic Details

Published in:	Frontiers in Pharmacology
Main Authors:	Fathi Abdul Malek, Petra Funk
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-02-01
Subjects:	Pelargonium sidoides root extract (EPs 7630) off-label use case reports COVID-19 spontaneous reporting safety
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2024.1335309/full